BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25210072)

  • 41. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
    Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
    J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.
    Wang JT; Wu UI; Lauderdale TL; Chen MC; Li SY; Hsu LY; Chang SC
    PLoS One; 2015; 10(3):e0121668. PubMed ID: 25794144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.
    Singh-Moodley A; Perovic O
    BMC Infect Dis; 2016 Oct; 16(1):536. PubMed ID: 27716102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant
    Han R; Shi Q; Wu S; Yin D; Peng M; Dong D; Zheng Y; Guo Y; Zhang R; Hu F;
    Front Cell Infect Microbiol; 2020; 10():314. PubMed ID: 32719751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The genotype and epidemiological feature of the Enterobacteriaceae carrying carbapenemase in China].
    Zhang J; Liu Y; Chen H; Cao B; Gao H; Li H; Wang H
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):116-20. PubMed ID: 24767163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis.
    Shahcheraghi F; Aslani MM; Mahmoudi H; Karimitabar Z; Solgi H; Bahador A; Alikhani MY
    J Med Microbiol; 2017 May; 66(5):570-576. PubMed ID: 28485708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early OXA-48-Producing
    Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland.
    Poirel L; Schrenzel J; Cherkaoui A; Bernabeu S; Renzi G; Nordmann P
    J Antimicrob Chemother; 2011 Aug; 66(8):1730-3. PubMed ID: 21628303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
    Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
    J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of in-house and commercial real time-PCR based carbapenemase gene detection methods in Enterobacteriaceae and non-fermenting gram-negative bacterial isolates.
    Smiljanic M; Kaase M; Ahmad-Nejad P; Ghebremedhin B
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):48. PubMed ID: 28693493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico.
    Bocanegra-Ibarias P; Garza-González E; Morfín-Otero R; Barrios H; Villarreal-Treviño L; Rodríguez-Noriega E; Garza-Ramos U; Petersen-Morfin S; Silva-Sanchez J
    PLoS One; 2017; 12(6):e0179651. PubMed ID: 28636666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART).
    Sheng WH; Badal RE; Hsueh PR;
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2981-8. PubMed ID: 23587958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
    Demir Y; Zer Y; Karaoglan I
    Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.